{"id":"https://openalex.org/W2014942547","doi":"https://doi.org/10.3111/13696998.2012.744316","title":"Assessing the role of patient support services on adherence rates in patients using glatiramer acetate for relapsing-remitting multiple sclerosis","display_name":"Assessing the role of patient support services on adherence rates in patients using glatiramer acetate for relapsing-remitting multiple sclerosis","publication_year":2012,"publication_date":"2012-10-26","ids":{"openalex":"https://openalex.org/W2014942547","doi":"https://doi.org/10.3111/13696998.2012.744316","mag":"2014942547","pmid":"https://pubmed.ncbi.nlm.nih.gov/23098539"},"language":"en","primary_location":{"id":"doi:10.3111/13696998.2012.744316","doi":"https://doi.org/10.3111/13696998.2012.744316","is_oa":true,"landing_page_url":"https://doi.org/10.3111/13696998.2012.744316","pdf_url":"https://www.tandfonline.com/doi/pdf/10.3111/13696998.2012.744316?needAccess=true","source":{"id":"https://openalex.org/S155267287","display_name":"Journal of Medical Economics","issn_l":"1369-6998","issn":["1369-6998","1941-837X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-c","anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320449","host_organization_name":"Informa","host_organization_lineage":["https://openalex.org/P4310320449"],"host_organization_lineage_names":["Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medical Economics","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.tandfonline.com/doi/pdf/10.3111/13696998.2012.744316?needAccess=true","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5028716784","display_name":"Janice L. Jones","orcid":"https://orcid.org/0000-0003-1655-297X","observed_orcids":["https://orcid.org/0000-0003-1655-297X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Janice L. Jones","raw_affiliation_strings":["Teva Neuroscience, 901 W. 104th St, Kansas City, MO 64131, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Teva Neuroscience, 901 W. 104th St, Kansas City, MO 64131, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111657350","display_name":"D. Scheidt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210139373","display_name":"Teva Pharmaceuticals (United States)","ror":"https://ror.org/03etg4523","country_code":"US","type":"company","lineage":["https://openalex.org/I4210109720","https://openalex.org/I4210139373"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Donna J. Scheidt","raw_affiliation_strings":["Teva Pharmaceuticals Kansas City, MOUSA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Teva Pharmaceuticals Kansas City, MOUSA","institution_ids":["https://openalex.org/I4210139373"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071046359","display_name":"Ranbir S. Kaushal","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210139373","display_name":"Teva Pharmaceuticals (United States)","ror":"https://ror.org/03etg4523","country_code":"US","type":"company","lineage":["https://openalex.org/I4210109720","https://openalex.org/I4210139373"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ranbir S. Kaushal","raw_affiliation_strings":["Teva Pharmaceuticals Kansas City, MOUSA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Teva Pharmaceuticals Kansas City, MOUSA","institution_ids":["https://openalex.org/I4210139373"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109686949","display_name":"Cathryn A. Carroll","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210139373","display_name":"Teva Pharmaceuticals (United States)","ror":"https://ror.org/03etg4523","country_code":"US","type":"company","lineage":["https://openalex.org/I4210109720","https://openalex.org/I4210139373"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Cathryn A. Carroll","raw_affiliation_strings":["Teva Pharmaceuticals Kansas City, MOUSA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Teva Pharmaceuticals Kansas City, MOUSA","institution_ids":["https://openalex.org/I4210139373"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5109686949"],"corresponding_institution_ids":["https://openalex.org/I4210139373"],"apc_list":null,"apc_paid":null,"fwci":0.8291,"has_fulltext":true,"cited_by_count":15,"citation_normalized_percentile":{"value":0.74752671,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"16","issue":"2","first_page":"213","last_page":"220"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11620","display_name":"Medication Adherence and Compliance","score":0.9735999703407288,"subfield":{"id":"https://openalex.org/subfields/2714","display_name":"Family Practice"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11620","display_name":"Medication Adherence and Compliance","score":0.9735999703407288,"subfield":{"id":"https://openalex.org/subfields/2714","display_name":"Family Practice"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":0.02239999920129776,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13970","display_name":"Pharmacy and Medical Practices","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glatiramer-acetate","display_name":"glatiramer acetate","score":0.9470000267028809},{"id":"https://openalex.org/keywords/relapsing-remitting-multiple-sclerosis","display_name":"relapsing-remitting multiple sclerosis","score":0.9940000176429749},{"id":"https://openalex.org/keywords/treatment-adherence","display_name":"medication adherence","score":0.9710000157356262},{"id":"https://openalex.org/keywords/medication-possession-ratio","display_name":"medication possession ratio","score":0.8489999771118164},{"id":"https://openalex.org/keywords/patient-support-programs","display_name":"patient support services","score":0.8389999866485596},{"id":"https://openalex.org/keywords/self-management-program","display_name":"self-management program","score":0.7990000247955322},{"id":"https://openalex.org/keywords/injection-training","display_name":"injection training","score":0.8489999771118164},{"id":"https://openalex.org/keywords/predictors-of-adherence","display_name":"predictors of adherence","score":0.6840000152587891}],"concepts":[{"id":"https://openalex.org/C2778577042","wikidata":"https://www.wikidata.org/wiki/Q418274","display_name":"Glatiramer acetate","level":3,"score":0.9375464916229248},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.923427939414978},{"id":"https://openalex.org/C151956035","wikidata":"https://www.wikidata.org/wiki/Q1132755","display_name":"Logistic regression","level":2,"score":0.6472233533859253},{"id":"https://openalex.org/C2780640218","wikidata":"https://www.wikidata.org/wiki/Q8277","display_name":"Multiple sclerosis","level":2,"score":0.5981455445289612},{"id":"https://openalex.org/C2779848557","wikidata":"https://www.wikidata.org/wiki/Q317749","display_name":"Copayment","level":4,"score":0.5926840901374817},{"id":"https://openalex.org/C64341305","wikidata":"https://www.wikidata.org/wiki/Q4919225","display_name":"Bivariate analysis","level":2,"score":0.5405792593955994},{"id":"https://openalex.org/C3020694758","wikidata":"https://www.wikidata.org/wiki/Q42417392","display_name":"Relapsing remitting","level":3,"score":0.5105236768722534},{"id":"https://openalex.org/C1862650","wikidata":"https://www.wikidata.org/wiki/Q186005","display_name":"Physical therapy","level":1,"score":0.4363902807235718},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.42635446786880493},{"id":"https://openalex.org/C2983635472","wikidata":"https://www.wikidata.org/wiki/Q334911","display_name":"Health insurance","level":3,"score":0.10203137993812561},{"id":"https://openalex.org/C160735492","wikidata":"https://www.wikidata.org/wiki/Q31207","display_name":"Health care","level":2,"score":0.10085955262184143},{"id":"https://openalex.org/C105795698","wikidata":"https://www.wikidata.org/wiki/Q12483","display_name":"Statistics","level":1,"score":0.08555737137794495},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.0},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.0},{"id":"https://openalex.org/C50522688","wikidata":"https://www.wikidata.org/wiki/Q189833","display_name":"Economic growth","level":1,"score":0.0},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000068717","descriptor_name":"Glatiramer Acetate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003430","descriptor_name":"Cross-Sectional Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007166","descriptor_name":"Immunosuppressive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016001","descriptor_name":"Confidence Intervals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016017","descriptor_name":"Odds Ratio","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016208","descriptor_name":"Databases, Factual","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016903","descriptor_name":"Drug Monitoring","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D020529","descriptor_name":"Multiple Sclerosis, Relapsing-Remitting","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D020529","descriptor_name":"Multiple Sclerosis, Relapsing-Remitting","qualifier_ui":"Q000451","qualifier_name":"nursing","is_major_topic":false},{"descriptor_ui":"D024802","descriptor_name":"Nurse's Role","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.3111/13696998.2012.744316","doi":"https://doi.org/10.3111/13696998.2012.744316","is_oa":true,"landing_page_url":"https://doi.org/10.3111/13696998.2012.744316","pdf_url":"https://www.tandfonline.com/doi/pdf/10.3111/13696998.2012.744316?needAccess=true","source":{"id":"https://openalex.org/S155267287","display_name":"Journal of Medical Economics","issn_l":"1369-6998","issn":["1369-6998","1941-837X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-c","anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320449","host_organization_name":"Informa","host_organization_lineage":["https://openalex.org/P4310320449"],"host_organization_lineage_names":["Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medical Economics","raw_type":"journal-article"},{"id":"pmid:23098539","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23098539","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of medical economics","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.3111/13696998.2012.744316","doi":"https://doi.org/10.3111/13696998.2012.744316","is_oa":true,"landing_page_url":"https://doi.org/10.3111/13696998.2012.744316","pdf_url":"https://www.tandfonline.com/doi/pdf/10.3111/13696998.2012.744316?needAccess=true","source":{"id":"https://openalex.org/S155267287","display_name":"Journal of Medical Economics","issn_l":"1369-6998","issn":["1369-6998","1941-837X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-c","anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320449","host_organization_name":"Informa","host_organization_lineage":["https://openalex.org/P4310320449"],"host_organization_lineage_names":["Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medical Economics","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320308604","display_name":"Biogen","ror":"https://ror.org/02jqkb192"},{"id":"https://openalex.org/F4320308970","display_name":"Teva Pharmaceutical Industries","ror":"https://ror.org/01wfv3m53"},{"id":"https://openalex.org/F4320322202","display_name":"IC Design Education Center","ror":"https://ror.org/005v57z85"},{"id":"https://openalex.org/F4320332200","display_name":"EMD Serono","ror":"https://ror.org/027zrs220"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2014942547.pdf","grobid_xml":"https://content.openalex.org/works/W2014942547.grobid-xml"},"referenced_works_count":31,"referenced_works":["https://openalex.org/W57263284","https://openalex.org/W147698845","https://openalex.org/W1590773783","https://openalex.org/W1963494741","https://openalex.org/W1968276320","https://openalex.org/W1968507597","https://openalex.org/W1970190011","https://openalex.org/W1973229471","https://openalex.org/W1980702540","https://openalex.org/W1989806530","https://openalex.org/W2000610858","https://openalex.org/W2003265473","https://openalex.org/W2011641866","https://openalex.org/W2021156693","https://openalex.org/W2025177594","https://openalex.org/W2027708193","https://openalex.org/W2033725597","https://openalex.org/W2049604880","https://openalex.org/W2059101486","https://openalex.org/W2062557300","https://openalex.org/W2064816281","https://openalex.org/W2081656032","https://openalex.org/W2092853759","https://openalex.org/W2094430860","https://openalex.org/W2102368961","https://openalex.org/W2129303710","https://openalex.org/W2138834872","https://openalex.org/W2140959461","https://openalex.org/W2154830573","https://openalex.org/W2345422376","https://openalex.org/W2412240552"],"related_works":["https://openalex.org/W2331315977","https://openalex.org/W2030251045","https://openalex.org/W1985883593","https://openalex.org/W2028483867","https://openalex.org/W3129350929","https://openalex.org/W2163461844","https://openalex.org/W2038982872","https://openalex.org/W2405944917","https://openalex.org/W2022619860","https://openalex.org/W2595572715"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"assess":[2,99],"predictors":[3,100],"of":[4,6,49,56,68,86,101,107,117,133,143,201],"achievement":[5],"80%":[7,102],"Medication":[8],"Possession":[9],"Ratio":[10],"(MPR)":[11],"in":[12,44],"patients":[13,23,38,109,118,134,183],"receiving":[14],"manufacturer-provided":[15,120],"self-management":[16,51],"services":[17],"for":[18,34,53,81,89],"relapsing-remitting":[19],"multiple":[20],"sclerosis":[21],"(RRMS)":[22],"taking":[24],"glatiramer":[25,227],"acetate":[26,228],"(Copaxone).":[27],"METHODS:":[28],"De-identified":[29],"patient":[30,73,221],"records":[31],"were":[32,76,96,125,151,174,198,215],"selected":[33],"study":[35,112],"inclusion":[36,113],"if":[37,158],"had":[39,60],"been":[40],"(1)":[41],"continuously":[42],"enrolled":[43],"one":[45],"or":[46,146],"more":[47,153,176],"aspects":[48],"the":[50,66,111,164],"program":[52],"a":[54,140],"minimum":[55],"24":[57],"months":[58],"and":[59,70,84,123,128,173],"adherence":[61,203,225],"measured":[62],"by":[63,163],"MPR":[64,142],"between":[65],"values":[67],"zero":[69],"one.":[71],"Baseline":[72],"univariate":[74],"measures":[75],"assessed":[77],"using":[78],"chi-squared":[79],"statistics":[80],"categorical":[82],"variables":[83],"Analysis":[85],"Variance":[87],"(ANOVA)":[88],"continuous":[90],"variables.":[91],"Bivariate":[92],"logistic":[93],"regression":[94],"models":[95],"used":[97],"to":[98,148,155,178,212,217,226],"MPR.":[103],"RESULTS:":[104],"A":[105],"total":[106],"5825":[108],"met":[110],"criteria.":[114],"About":[115],"70%":[116],"received":[119],"injection":[121,159],"training":[122,160],"75%":[124],"eligible":[126,182],"for,":[127],"utilized,":[129],"copayment":[130,185],"assistance;":[131],"74.3%":[132],"accessing":[135],"sponsor":[136],"provided":[137,162],"support":[138,222],"achieved":[139],"desired":[141],"greater":[144],"than":[145],"equal":[147],"80%.":[149],"Patients":[150,195],"40%":[152],"likely":[154,177],"reach":[156],"goal":[157,180],"was":[161],"manufacturer":[165],"(OR":[166,188,205],"=":[167,171,189,193,206,209],"1.435;":[168],"95%":[169,191],"CI":[170,192,208],"1.258-1.636)":[172],"30.6%":[175],"achieve":[179],"when":[181],"utilized":[184],"assistance":[186],"programs":[187,223],"1.306;":[190],"1.109-1.570).":[194],"reinitiating":[196],"treatment":[197],"at":[199],"risk":[200],"lower":[202],"rates":[204],"0.605;":[207],"0.476-0.769)":[210],"compared":[211],"those":[213],"who":[214],"new":[216],"therapy.":[218,229],"CONCLUSIONS:":[219],"Manufacturer-provided":[220],"improve":[224]},"counts_by_year":[{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}